TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
| Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
| Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
| Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
| Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
| Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
| Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
| Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
| Geduld E E | 8,000 | $1,122,000 | 0.70% |
| Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |